• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$13.99
▲ +0.165 (1.19%)

This chart shows the closing price for GLAPF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
NovDecJan$13.99Closing price on 01/13/25:
Get New Glanbia Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GLAPF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GLAPF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Glanbia in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $13.99.

This chart shows the closing price for GLAPF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
1/244/247/2410/241/251/26$9.68$13$16$19$22Closing price on 01/13/25: $13.99High$0.0000Average$0.0000Low$10.00M




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Glanbia. This rating has held steady since January 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/23/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/18/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/15/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/14/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/13/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/17/2023Credit Suisse GroupInitiated CoverageNeutral ➝ Neutral
1/6/2023Morgan StanleyInitiated CoverageEqual Weight
8/23/2022BarclaysBoost Target€16.50 ➝ €17.20
7/19/2022Berenberg BankLower Target€15.00 ➝ €14.00
4/14/2022Berenberg BankLower Target€16.00 ➝ €14.50
11/12/2021Berenberg BankReiterated RatingBuy
10/8/2021Kepler Capital MarketsDowngradeHold$14.30
8/17/2021BarclaysReiterated RatingOverweight
8/16/2021Berenberg BankReiterated RatingBuy
7/30/2021Kepler Capital MarketsDowngradeHold$11.50
5/10/2021Credit Suisse GroupReiterated RatingOutperform
5/10/2021Berenberg BankReiterated RatingBuy
3/26/2021Kepler Capital MarketsReiterated RatingHold
2/26/2021BarclaysReiterated RatingOverweight
2/26/2021Berenberg BankReiterated RatingBuy
2/12/2021Kepler Capital MarketsDowngradeHold
1/28/2021Kepler Capital MarketsDowngradeBuy ➝ Hold
12/11/2020Kepler Capital MarketsReiterated RatingBuy
10/18/2020Kepler Capital MarketsReiterated RatingBuy
9/1/2020Credit Suisse GroupInitiated CoverageOutperform
8/21/2020Kepler Capital MarketsReiterated RatingBuy
8/14/2020Morgan StanleyReiterated RatingOverweight
6/29/2020Kepler Capital MarketsReiterated RatingBuy
6/17/2020Morgan StanleyReiterated RatingOverweight
6/16/2020Kepler Capital MarketsUpgradeBuy
5/27/2020Kepler Capital MarketsReiterated RatingBuy
4/24/2020BarclaysReiterated RatingEqual Weight
4/7/2020Morgan StanleyReiterated RatingOverweight
4/7/2020Kepler Capital MarketsReiterated RatingBuy
(Data available from 1/14/2020 forward)

News Sentiment Rating

0.82 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/18/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/18/2024
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/17/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/16/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/16/2024
  • 5 very positive mentions
  • 16 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/15/2024
  • 3 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/15/2024
  • 4 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/14/2025

Current Sentiment

  • 4 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Glanbia logo
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; property leasing; business services; management solutions; weight management; flavor solutions; and bioactive solutions businesses. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, SlimFast, think!, Amazing Grass, Body & Fit, and LevlUp brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Read More

Today's Range

Now: $13.99
Low: $13.99
High: $13.99

50 Day Range

MA: $15.12
Low: $13.83
High: $16.75

52 Week Range

Now: $13.99
Low: $13.83
High: $20.00

Volume

108 shs

Average Volume

518 shs

Market Capitalization

N/A

P/E Ratio

27.09

Dividend Yield

0.87%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Glanbia?

The following Wall Street research analysts have issued research reports on Glanbia in the last year:
View the latest analyst ratings for GLAPF.

What is the current price target for Glanbia?

0 Wall Street analysts have set twelve-month price targets for Glanbia in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Glanbia in the next year.
View the latest price targets for GLAPF.

What is the current consensus analyst rating for Glanbia?

Glanbia currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for GLAPF.

What other companies compete with Glanbia?

Other companies that are similar to Glanbia include (BVII), 30DC, Aalberts, Absa Group and Air China. Learn More about companies similar to Glanbia.

How do I contact Glanbia's investor relations team?

Glanbia's physical mailing address is Glanbia House, , . The company's listed phone number is 353567772200. The official website for Glanbia is www.glanbia.com. Learn More about contacing Glanbia investor relations.





Receive Glanbia News & Ratings Daily
Sign up to receive the latest news and ratings for Glanbia and its competitors with PriceTargets.com’s free daily newsletter.